Several studies found that adiponectin acted as a negative regulator of estrogen receptor alpha negative breast cancer, while adiponectin might restrain the development of estrogen receptor alpha positive breast cancer when at relatively low concentrations (57–60). This evidence concerns the gene ADIPOQ and breast carcinoma.